European Archives - Page 141 of 1448 - European Medical Journal

4 Dec 2025

Evidence on VNS in the Modern DRE Treatment Landscape

In this interactive article, explore how drug-resistant epilepsy is linked to decreased quality of life and increased risk of morbidity and..

Clinical trial participant

ABPI: UK falling behind on clinical trial recruitment

According to the body, patient participation in industry-sponsored trials has fallen by 25% between 2022/23 and 2024/25.

Aluminum Adjuvant Imject Alum Drives Liver Fibrosis in Novel Mouse Model

High-dose aluminum adjuvant Imject Alum induces immune-mediated liver inflammation and fibrosis in mice, offering a new preclinical model that mirrors human cirrhosis biology.

New Guideline Enhances Safe csDMARD Use Nationwide

BSR has published an updated guideline on the safe use of csDMARDs, introducing new evidence, paediatric guidance, and risk-adaptive monitoring across the full life course.

glioblastoma

Engineered Virus Shows New Hope Against Deadly Brain Cancer

Engineered herpes virus targets glioblastoma cells, destroying tumours while activating immune defences in preclinical brain cancer models.

Anna Minchom, Royal Marsden Hospital and the Institute of Cancer Research, London.

Onc Now: Episode 31: Tackling Drug Resistance and Shaping New Therapies

Anna Minchom, Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital, explains the drug development process, key considerations in designing and conducting a trial, and the challenges in drug resistance.

Faster, More Accessible Test Could Transform Tuberculosis Diagnosis

New test shows high sensitivity for tuberculosis, providing a faster, near-point-of-care option for early detection and prevention.

Shifts in Blood Lipids Linked to Early Primary Biliary Cholangitis

Early-stage primary biliary cholangitis shows distinct blood lipid changes tied to inflammation and fibrosis, offering clues to disease activity and potential new biomarkers.

JAK2 Gene Fusions Found Widely Across Cutaneous T-Cell Lymphomas

A large retrospective study shows JAK2 gene fusion occurs in both aggressive and indolent cutaneous T-cell lymphomas, offering new insight into diagnosis and targeted treatment.

Fast Five: Nicolas Girard on Lung Cancer Updates

In this episode, Nicolas Girard discusses the latest developments in lung cancers presented at ESMO 2025.